Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
01/1996
01/04/1996WO1996000205A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same
01/04/1996WO1995031985A3 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
01/04/1996CA2192711A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same
01/03/1996EP0690050A1 (Thia)cycloalkyl(b) indole derivatives as 5-lipoxygenase inhibitors
01/03/1996EP0689544A1 Process for production of an imidazole derivative
01/02/1996US5480904 Benzothiophene compound
12/1995
12/29/1995CA2152725A1 (thia)cycloalkyl [b] indoles; process for preparing the same and pharmaceutical compositions containing them
12/28/1995WO1995035118A1 Contraceptive vaccine
12/28/1995WO1995035107A1 Endothelin receptor antagonists
12/28/1995CA2193206A1 Contraceptive vaccine
12/27/1995EP0688565A1 Tablet, capsule, or granule comprising desogestrel
12/27/1995EP0688365A1 Fertility regulation with transforming growth factor beta
12/27/1995EP0688209A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom
12/27/1995EP0584159B1 Nutrient preparation
12/26/1995US5478956 8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing them
12/26/1995US5478938 Antagonists for angiotensin II receptors; hypotensive, cardiotonic agents; cognitive activators
12/26/1995US5478856 Styrene derivatives and salts thereof
12/26/1995US5478852 Administering
12/26/1995US5478725 Contacting endometrium sample with monoclonal antibody specific for integrin, assaying, correlating absence with endometriosis
12/26/1995US5478571 Process for the preparation of substantially alcohol free pharmaceutical compositions
12/22/1995WO1994028924A1 Combination of angiotensin converting enzyme inhibitors and aii antagonists
12/22/1995CA2165410A1 Combination of angiotensin converting enzyme inhibitors and all antagonists
12/21/1995WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
12/20/1995EP0687256A1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions
12/20/1995EP0687251A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists
12/20/1995CN1113438A Emulsive medicine for curing dam's acyesis and production thereof
12/19/1995US5476856 Treatment of PAF and histamine-mediated diseases with 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
12/19/1995US5476851 Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase
12/19/1995US5476847 Treating cardiovascular, gastrointestinal, urogenital disorders
12/14/1995WO1995033752A1 Endothelin receptor antagonists
12/14/1995WO1995033748A1 Endothelin receptor antagonists
12/14/1995WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
12/14/1995WO1995033477A1 Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
12/14/1995WO1995033454A1 Uterine fibroid treatment
12/14/1995CA2192061A1 Uterine fibroid treatment
12/13/1995EP0686629A2 Cyclohexyl tachykinine receptor antagonists
12/13/1995EP0686627A2 Substituted perfluoroalkylguanidines, process for their preparation, their use as medicine or diagnostic as well as medicines containing them
12/13/1995EP0686037A1 Hormone replacement therapy
12/12/1995US5474999 Therapeutic amides
12/12/1995US5474995 Phenyl heterocycles as cox-2 inhibitors
12/12/1995US5474774 Adhesion inhibiting composition
12/11/1995CA2150992A1 Cyclohexyl tachykinin receptor antagonists
12/07/1995WO1995033050A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors
12/07/1995WO1995032725A1 Angiotensin ii for improving fertilization
12/07/1995WO1995032708A1 Use of anti-vegf agents in the treatment of endometriosis
12/07/1995CA2191071A1 Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof used as growth factor inhibitors
12/07/1995CA2191070A1 Use of anti-vegf agents in the treatment of endometriosis
12/06/1995EP0684949A1 Chemical compounds
12/06/1995EP0684825A1 Method of preventing or inhibiting fertilization
12/05/1995US5472977 Administering 3,4-(diphenyl)chromans
12/05/1995US5472962 Antiestrogenic agents
12/05/1995US5472694 Method for manufacturing tea by treating the leaves of Cyclobalanopsis stenophylla
11/1995
11/30/1995WO1995031991A2 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
11/30/1995WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase
11/29/1995EP0684257A1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them
11/29/1995EP0684241A1 N-pyridyl carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them
11/29/1995EP0683792A1 Lhrh antagonists having modified aminoacyl residues at postions 5 and 6
11/29/1995EP0540560B1 Ancrod-like proteins, their preparation and their use
11/29/1995CN1112444A Treatment of infertility and enhancement of fertilization capacity in mammalian males
11/29/1995CN1112416A Cosmetic or pharmaceutical compositions consisting of liposomes
11/28/1995US5470977 Serotonin 1A receptor agonists
11/28/1995US5470955 Antibodies for binding monoclonal antibody polypeptides
11/28/1995US5470947 CHRH antagonists with low histamine release
11/28/1995US5470867 Imidazoles and their salts having antagonistic activity to angiotesin II recetors
11/28/1995US5470854 Antiestrogens
11/28/1995US5470826 Single chain proteins with FHS suppressing activity isolated from follicular fluid and uses thereof
11/28/1995US5470588 Hydrogen iodide
11/23/1995WO1995031543A1 Dna encoding the beta subunit of a mammalian 'maxi-k' potassium channel
11/23/1995WO1995031537A1 HUMAN OXALYL-CoA DECARBOXYLASE
11/23/1995WO1995031178A1 Mucoadhesive emulsions containing cyclodextrin
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/22/1995EP0683159A1 Substituted furoxanes
11/22/1995CN1112364A Piperazine derivatives and salts thereof
11/22/1995CN1112112A New bicyclic derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
11/22/1995CN1112019A Novel process for the preparation of cetrorelix lyophilisate
11/22/1995CN1111988A Use of aromatic steroids substituted in position 3 by a disubstituted aminoalkyloxy chain in order to obtain a medicament intended to control fertility and in particular male fertility, and the pharma
11/21/1995US5468879 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
11/21/1995US5468757 For treating stroke or myocardial infarction in humans
11/21/1995US5468736 Hormone replacement therapy
11/21/1995CA2149854A1 Substituted furoxanes
11/21/1995CA1337591C Therapeutic composition comprising oestrogen and antioestrogen
11/16/1995WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME
11/16/1995WO1995030751A1 Lanthionine-containing antimicrobial compound
11/16/1995CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same
11/16/1995CA2186621A1 Lanthionine-containing antimicrobial compound
11/15/1995EP0681842A2 Ligand-mediated immunofunctional hormone binding protein assay method
11/15/1995EP0681835A1 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
11/15/1995EP0681678A1 Self-loading grenade launcher
11/15/1995EP0681582A1 Pyrazole derivatives and pharmaceutical compositions thereof
11/15/1995EP0448707B1 Bacteria harboring expression vectors encoding human CILIARY NEUROTROPHIC FACTOR (h-CNTF), their use in the production of h-CNTF, antibodies to h-CNTF and the use of h-CNTF in medical treatment
11/15/1995CN1111618A Urea-subtituted benzoylguanidines, proces for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/1995CN1111512A Medical composition for prevention of early pregnancy
11/15/1995CN1111507A Controlled release oxybutynin formulations
11/14/1995US5466712 Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones
11/14/1995US5466709 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes
11/14/1995US5466701 Saccharin derivative proteolytic enzyme inhibitors
11/14/1995US5466584 Oxytocin receptor and DNA coding therefor
11/12/1995CA2149091A1 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
1 ... 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 ... 557